|
|
|
|
LEADER |
01885 am a22002413u 4500 |
001 |
106336 |
042 |
|
|
|a dc
|
100 |
1 |
0 |
|a Carney, Daniel W.
|e author
|
100 |
1 |
0 |
|a Massachusetts Institute of Technology. Department of Biology
|e contributor
|
100 |
1 |
0 |
|a Schmitz, Karl Robert
|e contributor
|
100 |
1 |
0 |
|a Sauer, Robert T.
|e contributor
|
700 |
1 |
0 |
|a Scruse, Anthony C.
|e author
|
700 |
1 |
0 |
|a Sello, Jason K.
|e author
|
700 |
1 |
0 |
|a Schmitz, Karl Robert
|e author
|
700 |
1 |
0 |
|a Sauer, Robert T.
|e author
|
245 |
0 |
0 |
|a Examination of a Structural Model of Peptidomimicry by Cyclic Acyldepsipeptide Antibiotics in Their Interaction with the ClpP Peptidase
|
260 |
|
|
|b Wiley Blackwell,
|c 2017-01-10T21:24:37Z.
|
856 |
|
|
|z Get fulltext
|u http://hdl.handle.net/1721.1/106336
|
520 |
|
|
|a The cyclic acyldepsipeptide (ADEP) antibiotics act by binding the ClpP peptidase and dysregulating its activity. Their exocyclic N-acylphenylalanine is thought to structurally mimic the ClpP-binding, (I/L)GF tripeptide loop of the peptidase's accessory ATPases. We found that ADEP analogues with exocyclic N-acyl tripeptides or dipeptides resembling the (I/L)GF motif were weak ClpP activators and had no bioactivity. In contrast, ADEP analogues possessing difluorophenylalanine N-capped with methyl-branched acyl groups-like the side chains of residues in the (I/L)GF motifs-were superior to the parent ADEP with respect to both ClpP activation and bioactivity. We contend that the ADEP's N-acylphenylalanine moiety is not simply a stand-in for the ATPases' (I/L)GF motif; it likely has physicochemical properties that are better suited for ClpP binding. Further, our finding that the methyl-branching on the acyl group of the ADEPs improves activity opens new avenues for optimization.
|
520 |
|
|
|a National Institutes of Health (U.S.) (Grant GM-101988)
|
546 |
|
|
|a en_US
|
655 |
7 |
|
|a Article
|
773 |
|
|
|t ChemBioChem
|